Literature DB >> 4022283

Surgical considerations in the initial repair of meningomyelocele and the introduction of a technical modification.

J L Venes.   

Abstract

Tethering of the spinal cord has been increasingly recognized as a cause of late deterioration in the child with repaired meningomyelocele. Findings at reoperation include dense arachnoiditis, dermal inclusion cysts, fibrolipoma of the filum terminale, and, on occasion, foreign body granulomas. This article reviews four key steps in meningomyelocele repair and the guidelines for detection of surgically remediable lesions associated with this disorder. In addition, it proposes a modification of the standard dural closure that may reduce the incidence of contributory adhesive arachnoiditis by the creation of a capacious cerebrospinal fluid space about the neural plaque.

Entities:  

Mesh:

Year:  1985        PMID: 4022283     DOI: 10.1227/00006123-198507000-00022

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  4 in total

Review 1.  Foreign body reactions causing spinal cord tethering: a case-based update.

Authors:  Juan F Martínez-Lage; Belen Ferri Niguez; María José Almagro; María Cristina Rodriguez; Miguel A Pérez-Espejo
Journal:  Childs Nerv Syst       Date:  2010-03-11       Impact factor: 1.475

Review 2.  Dural substitutes for spina bifida repair: past, present, and future.

Authors:  Marcos M Miyabe; Kendall P Murphy; Marc Oria; Soner Duru; Chia-Ying Lin; Jose L Peiro
Journal:  Childs Nerv Syst       Date:  2022-04-04       Impact factor: 1.475

3.  The initial treatment of meningocele and myelomeningocele lesions in adulthood: experiences with seven patients.

Authors:  Kamil Melih Akay; Engin Gönül; Emin Ocal; Erdener Timurkaynak
Journal:  Neurosurg Rev       Date:  2002-06-18       Impact factor: 3.042

4.  Surgical treatment of late neurological deterioration in children with myelodysplasia.

Authors:  M Caldarelli; C Di Rocco; C Colosimo; G Fariello; M Di Gennaro
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.